Journal Article Summary
The article investigates the effectiveness of a crush-resistant formulation of oxymorphone hydrochloride, designed to deter abuse by individuals who misuse prescription opioids. The rise in opioid abuse, particularly through methods like snorting or injecting, poses significant public health challenges, including increased rates of addiction and overdose. By developing formulations that are harder to tamper with, the pharmaceutical industry aims to reduce the appeal of these medications to abusers, potentially lowering the risks associated with their misuse.
In the study, experienced opioid abusers were asked to attempt to prepare both a crush-resistant formulation (DCR) and a non-crush-resistant formulation (OXM) for intranasal and intravenous use. The researchers analyzed the particle sizes of the tampered tablets and the yield of active drug extracted from them. Results showed that significantly fewer particles from the DCR formulation were small enough to be suitable for snorting compared to the OXM formulation, and most participants expressed a reluctance to use the DCR product for either method of abuse. Despite both formulations yielding low amounts of active drug, the DCR was perceived as less valuable by participants, indicating that it may be more effective in deterring abuse.
However, the study has limitations, including the reliance on self-reported data and the potential for participants to change their behavior outside the controlled environment of the study. Readers should be aware that while the DCR formulation may reduce the likelihood of abuse, it does not eliminate the risks associated with opioid use. It is essential for patients and caregivers to discuss any concerns about opioid medications with healthcare professionals, including the potential for misuse and the importance of safe storage and disposal practices.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication. Always consult a licensed healthcare professional before using a medical device.
Article Cited
- Vosburg Suzanne K., Jones Jermaine D., Manubay Jeanne M., Ashworth Judy B., Benedek Irma H., Comer Sandra D.. Assessment of a formulation designed to be crush-resistant in prescription opioid abusers. Drug and alcohol dependence 2012. DOI: 10.1016/j.drugalcdep.2012.05.013. PMID: 22721679. PMCID: PMC3654549.
Featured Pill Pals Product
Pill Pals - Pill Cutter, Crusher, Splitter, and Holder (3 in 1) --- Three in One --- Dukal --- Over The Counter
Pill Pals – Pill Cutter, Crusher, Splitter, and Holder (3 in 1) — Three in One — Dukal — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
